Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘team’

« Older Entries

New method for predicting cancer virulence

By on Friday, May 24th, 2013 | No Comments

A new way of tackling cancer and predicting tumor virulence are has been reported by a team of researchers. The scientists have shown that, in all cancers, an aberrant activation of numerous genes specific to other tissues occurs. For example, in lung cancers, the tumorous cells express genes specific to the production of spermatozoids, which should be silent.

Read More...

Grapefruit-Derived Nanovectors Provide A Secret Weapon In Medical Drug Delivery

By on Thursday, May 23rd, 2013 | No Comments

University of Louisville researchers have uncovered how to create nanoparticles using natural lipids derived from grapefruit, and have discovered how to use them as drug delivery vehicles. UofL scientists Huang-Ge Zhang, D.V.M., Ph.D., Qilong Wang, Ph.D., and their team have published their findings in Nature Communications. Lipids derived from grapefruit…

Read More...

Man walks across America for ovarian cancer awareness

By on Wednesday, May 22nd, 2013 | No Comments

Dave Brown started his journey in Atlantic City, NJ, heading toward San Francisco, CA. Our team caught up with him as he passed through mid-Missouri. Dave’s …

Read More...

Study identifies key protein for cell death

By on Thursday, May 16th, 2013 | No Comments

When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their DNA. A new finding from MIT’s Center for Environmental Health Sciences and Koch Institute for Integrative Cancer Research may offer a way to overcome that resistance: The team has identified a key protein involved in an alternative death pathway known as programmed necrosis. Drugs that mimic the effects of this protein could push cancer cells that are resistant to apoptosis into necrosis instead.

Read More...

Mapping the embryonic epigenome: How genes are turned on and off during early human development

By on Thursday, May 9th, 2013 | No Comments

A large, multi-institutional research team has published a sweeping analysis of how genes are turned on and off to direct early human development.

Read More...

Sensors & Cancer Treatment, 60 seconds of inspiration, Dr Sinéad O’Keeffe, University of Limerick

By on Thursday, May 9th, 2013 | No Comments

Dr Sinéad O’Keeffe, UL researcher applying sensor technology to the treatment of cancer patients undergoing radiotherapy. Sinéad and her team at the Optical Fibre Sensors Research Centre,…

Read More...

Sensors & Cancer Treatment, 60 seconds of inspiration, Dr Sinéad O’Keeffe, University of Limerick

By on Thursday, May 9th, 2013 | No Comments

Dr Sinéad O’Keeffe, UL researcher applying sensor technology to the treatment of cancer patients undergoing radiotherapy. Sinéad and her team at the Optical Fibre Sensors Research Centre,…

Read More...

My cancer diagnosis and treatment

By on Wednesday, May 8th, 2013 | No Comments

After receiving the news that he had cancer, David soon had the support of AXA PPP healthcare’s dedicated team of nurses. They were able to take away unwante…

Read More...

Fusion-Guided Biopsy Improves Prostate Cancer Detection

By on Tuesday, May 7th, 2013 | No Comments

North Shore-LIJ’s prostate cancer team is the first to use the commercial version of a new prostate fusion biopsy technology, which combines magnetic resonan…

Read More...

Case Western researchers develop a novel method to disrupt a cancer growth signaling pathway

By on Sunday, May 5th, 2013 | No Comments

A common cancer pathway causing tumor growth is now being targeted by a number of new cancer drugs and shows promising results. A team of researchers at Case Western Reserve University School of Medicine (home of the Case Comprehensive Cancer Center) have developed a novel method to disrupt this growth signaling pathway, with findings that suggest a new treatment for breast, colon, melanoma and other cancers. The research team has pinpointed the cancer abnormality to a mutation in a gene called PIK3CA that results in a mutant protein, which may be an early cancer switch.

Read More...
« Older Entries